University Hospital Tuebingen, CCU Translational Immunology

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Belimumab in Patients with Chronic Lymphocytic Leukemia	Chronic Lymphoid Leukemia in Relapse	Active, not recruiting	Phase 2	2024-12-09		NCT05069051

Clinical trials